A Study With Darapladib to Collect Tolerability Information

Clinical trial NCT00704431 · COMPLETED

Trial details

NCT number: NCT00704431
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2008-05-01
Primary completion: 2008-10-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.